Thermomind
Early-stage Breast Cancer Detection
Company Overview
Snapshot
Founded in April 2022 by Najeeb Ayoub and Larisa Adamyan, Thermomind operated with 1–10 employees. The company raised $12 million across one funding round. In May 2025, Thermomind ceased operations.
Business overview
Thermomind is a technology company developing advanced thermal imaging solutions for the healthcare industry. The company utilizes thermal sensing technology and artificial intelligence to provide accurate imaging for medical professionals. Its core product is a non-contact and radiation-free screening modality for early breast cancer detection, which analyzes thermal data to identify metabolic abnormalities. This technology aims to offer a scalable, efficient, and cost-effective screening experience, serving patients and healthcare providers in the Digital Medical Diagnostics and Medical Devices sectors.
Strategic signal
Thermomind ceased operations in May 2025, indicating a significant closure event for the company. This development signals to investors and innovation teams that the company's technology and business model did not achieve sustainable viability, despite earlier positive news regarding grants and clinical trials.
Log in to access full profile ›Company Intelligence Q&A
- What is Thermomind's primary focus?
- Thermomind focuses on revolutionizing early-stage breast cancer detection through advanced thermal imaging solutions combined with artificial intelligence.
- When was Thermomind founded and by whom?
- Thermomind was founded in April 2022 by Najeeb Ayoub and Larisa Adamyan.
- What is the status of Thermomind?
- Thermomind is non-active, having ceased operations in May 2025.
- What was a significant financial milestone for Thermomind?
- Thermomind secured a grant of 11.5 million euros from the European Commission in August 2022 for a four-year project to develop its scanning technology.
- What technology does Thermomind utilize for breast cancer detection?
- Thermomind's technology combines highly sensitive thermal sensing hardware with sophisticated AI systems to analyze thermal data and identify metabolic abnormalities indicative of breast cancer. It is designed as a non-contact and radiation-free screening modality.